Key statistics
As of last trade, Biora Therapeutics Inc (4ZU:FRA) traded at 5.10, 31.44% above the 52 week low of 3.88 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 5.10 |
Low | 5.10 |
Bid | -- |
Offer | -- |
Previous close | 5.10 |
Average volume | -- |
---|---|
Shares outstanding | 4.34m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 11.72m USD |
EPS (TTM) | -55.72 USD |
Data delayed at least 15 minutes, as of Oct 17 2024 14:41 BST.
More ▼
Announcements
- Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
- Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
- Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
- Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
- Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
- Biora Therapeutics Achieves ISO 13485 Certification
- Biora Therapeutics Announces Positive Nasdaq Listing Decision
- Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
More ▼